Cargando…
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma
Absent in melanoma 2 (AIM2) as an immune regulator for the regulation of tumor-associated macrophages (TAMs) function is unclear in tumor development. Here, the AIM2 function was investigated in TAMs-mediated malignant behaviors of renal carcinoma. The correlation analysis result showed that the AIM...
Autores principales: | Chai, Dafei, Zhang, Zichun, Shi, Shang yuchen, Qiu, Dong, Zhang, Chen, Wang, Gang, Fang, Lin, Li, Huizhong, Tian, Hui, Li, Hailong, Zheng, Junnian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823216/ https://www.ncbi.nlm.nih.gov/pubmed/33493800 http://dx.doi.org/10.1016/j.tranon.2021.101018 |
Ejemplares similares
-
Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer
por: Chai, Dafei, et al.
Publicado: (2020) -
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy
por: Chai, Dafei, et al.
Publicado: (2022) -
Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses
por: Chai, Dafei, et al.
Publicado: (2021) -
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022)